Mark Israel named executive director of Israel Cancer Research Fund

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Mark Israel, a pediatric oncologist and translational scientist, was appointed national executive director of the Israel Cancer Research Fund, a nonprofit organization dedicated solely to funding cancer research in Israel.

Israel joins ICRF from the Geisel School of Medicine at Dartmouth College, where he is a professor in the Department of Pediatrics, Medicine, and Molecular and Systems Biology. From 2001 to 2016, Israel served as the director of Dartmouth’s Norris Cotton Cancer Center.

For the last 12 years, Israel has been a volunteer member of the ICRF’s scientific review panel and the chair of the panel that evaluates translational cancer research proposals.

“Cancer research has never been more exciting or promising—and that is particularly true in Israel,” Israel said in a statement. “Israeli science knows no bounds. ICRF provides a singular opportunity to help build more recognition and support for the world-class cancer research of Israeli scientists, and to arm and empower its finest practitioners with the resources necessary to change the world.”

Table of Contents

YOU MAY BE INTERESTED IN

The California Institute for Regenerative Medicine, a state agency tasked with awarding billions of dollars of scientific funding for stem cell and gene therapy, has rescinded a controversial policy that was disrupting the flow of funding to cancer research.
NCI has emerged relatively unscathed in the president’s FY 2027 budget request that would slash $15.8 billion from HHS funding, cut NIH overall by about 10%, eliminate three NIH institutes and centers, and move the Institute for Environmental Health Sciences and its circa $1 billion budget out of NIH.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login